| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |